RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Paul B. Tchounwou to Cisplatin

Back to Details
This is a "connection" page, showing publications Paul B. Tchounwou has written about Cisplatin.
Paul B. Tchounwou
Connection Strength
2.051
Cisplatin
  1. Dasari S, Njiki S, Mbemi A, Yedjou CG, Tchounwou PB. Pharmacological Effects of Cisplatin Combination with Natural Products in Cancer Chemotherapy. Int J Mol Sci. 2022 Jan 28; 23(3).
    View in: PubMed
    Score: 0.819
  2. Kumar S, Tchounwou PB. Molecular mechanisms of cisplatin cytotoxicity in acute promyelocytic leukemia cells. Oncotarget. 2015 Dec 01; 6(38):40734-46.
    View in: PubMed
    Score: 0.534
  3. Dasari S, Tchounwou PB. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol. 2014 Oct 05; 740:364-78.
    View in: PubMed
    Score: 0.486
  4. Kumar S, Tchounwou PB. p53 as a unique target of action of cisplatin in acute leukaemia cells. J Cell Mol Med. 2022 09; 26(17):4727-4739.
    View in: PubMed
    Score: 0.212
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support